Table 1 Characteristics of 137 individuals with mycobacterial and bacterial sputum sample tests
Median (IQR) or N (%) | |
|---|---|
Age (yrs) | 52 (37–64) |
Male | 74 (54) |
HIV infection | 4 (3) |
Current smoking | 35 (26) |
Previous pulmonary TB | 51 (37) |
Number of times TB treateda | |
1 | 41/50 (80) |
2+ | 10/50 (20) |
Symptoms at presentation | |
Shortness of breath | 74 (54) |
Cough | 132 (96) |
Hemoptysis | 28 (20) |
Chest pain | 68 (50) |
Fever | 42 (31) |
Weight loss | 90 (66) |
Reported medication use at presentation | |
Antimicrobials prior to presentation | 68 (50) |
Antibacterials | 10/68 (15) |
Anti-TB | 2/68 (3) |
Unknown | 56/68 (82) |
Other medications prior to presentation | 71 (52) |
Clinical chest x-ray interpretation | |
Normal chest x-ray | 18 (13) |
Cavitary lesion(s) | 14 (10) |
Infiltrates and/or consolidation | 84 (61) |
Fibrosis | 17 (12) |
Bronchiectasis and/or bronchitis | 4 (3) |
Pathogenic organisms identified in sputum sample | |
None | 50 (37) |
TB only | 27 (20) |
Bacteria only | 47 (34) |
TB and bacteria | 13 (9) |